Published in Lancet on January 25, 1975
Letter: Erythema nodosum and brucellosis. Br Med J (1976) 0.75
British Hypertension Society guidelines for hypertension management 1999: summary. BMJ (1999) 8.80
A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens (2008) 6.82
Survey of use of anticoagulation in patients with atrial fibrillation. BMJ (1993) 5.71
Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens (2002) 4.93
Double-blind randomised trial of modest salt restriction in older people. Lancet (1997) 3.96
Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev (2004) 3.90
Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies. J Hum Hypertens (2007) 3.20
Renal artery stenosis masquerading as congestive heart failure. Lancet (1993) 3.10
Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet (1982) 3.07
Sarcoidosis, thyroiditis, and Addison's disease. Lancet (1970) 2.84
Better blood pressure control: how to combine drugs. J Hum Hypertens (2003) 2.19
Salt--more adverse effects. Lancet (1996) 2.17
Is "idiopathic" edema idiopathic? Lancet (1979) 2.11
Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension. Kidney Int (1980) 2.01
Diuretic-induced oedema. Lancet (1975) 1.84
Evidence for a circulating sodium transport inhibitor in essential hypertension. Br Med J (Clin Res Ed) (1981) 1.84
Moderate potassium supplementation in essential hypertension. Lancet (1982) 1.83
Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension. J Hypertens (1996) 1.81
Measurement of plasma renin activity by radioimmunoassay after prolonged cold storage. Clin Chim Acta (1978) 1.77
The measurement of angiotensin-converting enzyme in subjects receiving captopril. N Engl J Med (1980) 1.72
Familial Guillain-Barré syndrome. Lancet (1965) 1.71
Fortnightly review: Beneficial effects of potassium. BMJ (2001) 1.59
Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per year. J Hum Hypertens (2003) 1.59
Platelet volume is not increased in essential hypertension. J Hum Hypertens (1994) 1.48
Mineralocorticoid deficiency in HIV infection. BMJ (1989) 1.43
Maintenance of blood pressure by the renin-angiotensin system in normal man. Nature (1981) 1.42
Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet (1998) 1.42
Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens (1991) 1.39
Effects of changes in dietary sodium intake and saline infusion on immunoreactive atrial natriuretic peptide in human plasma. Lancet (1985) 1.38
The use of HMG Co-A reductase inhibitors following acute myocardial infarction in hospital practice. Postgrad Med J (1998) 1.37
Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. Am J Med (1994) 1.37
Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet (1986) 1.32
Sodium is more important than calcium in essential hypertension. Hypertension (1985) 1.26
Long term reduction in sodium balance: possible additional mechanism whereby nifedipine lowers blood pressure. BMJ (1990) 1.21
Structural skin capillary rarefaction in essential hypertension. Hypertension (1999) 1.21
Sodium restriction lowers high blood pressure through a decreased response of the renin system--direct evidence using saralasin. J Hypertens (1985) 1.21
Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol. Br Med J (Clin Res Ed) (1982) 1.18
Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart (2003) 1.16
Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension (1999) 1.15
Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives. Hypertension (1998) 1.15
Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme. Br Med J (1979) 1.14
Hyperthyroidism and a parathyroid adenoma complicating lithium treatment. Lancet (1977) 1.12
Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man. Br J Clin Pharmacol (1976) 1.08
Dietary salt and blood pressure. Lancet (1994) 1.08
Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens (1993) 1.04
Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study. Br Med J (Clin Res Ed) (1987) 1.04
Effect of salt intake on renal excretion of water in humans. Hypertension (2001) 1.04
Maximization of skin capillaries during intravital video-microscopy in essential hypertension: comparison between venous congestion, reactive hyperaemia and core heat load tests. Clin Sci (Lond) (1999) 1.04
Effect of sodium intake on ability of human plasma to inhibit renal Na+-K+-adenosine triphosphatase in vitro. Lancet (1981) 1.02
Capillary rarefaction in the forearm skin in essential hypertension. J Hypertens (1995) 1.01
Moderate potassium chloride supplementation in essential hypertension: is it additive to moderate sodium restriction? Br Med J (Clin Res Ed) (1985) 1.01
A randomized crossover study to compare the blood pressure response to sodium loading with and without chloride in patients with essential hypertension. J Hypertens (1988) 1.01
A family with autosomal dominant polycystic kidney disease not linked to chromosome 16p13.3. Clin Genet (1993) 1.00
Diuretics and oedema: how to avoid rebound sodium retention. Lancet (1992) 1.00
Contrasting effects of nifedipine, captopril, and propranolol in normotensive and hypertensive subjects. J Cardiovasc Pharmacol (1982) 0.99
Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine. J Cardiovasc Pharmacol (1985) 0.98
Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects. Br Med J (Clin Res Ed) (1981) 0.98
Lack of effect of oral magnesium on high blood pressure: a double blind study. Br Med J (Clin Res Ed) (1985) 0.98
Physiology: cardiac peptides and the control of sodium excretion. Nature (1984) 0.97
Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens (1996) 0.97
Acute and sustained changes in sodium balance during nifedipine treatment in essential hypertension. Am J Med (1991) 0.96
Dietary sodium and potassium intake and blood pressure. Lancet (1983) 0.96
Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension. J Hum Hypertens (1991) 0.95
Letter: Saralasin bolus test. Lancet (1975) 0.95
Sodium and blood pressure. Curr Opin Cardiol (2002) 0.95
The natriuretic hormone and essential hypertension. Lancet (1982) 0.94
Reduction of salt intake during converting enzyme inhibitor treatment compared with addition of a thiazide. Hypertension (1995) 0.94
Transepithelial sodium absorption is increased in people of African origin. Hypertension (2001) 0.94
Interested in developing a national programme to reduce dietary salt? J Hum Hypertens (2011) 0.93
The acute response to nifedipine is related to pre-treatment blood pressure. Postgrad Med J (1983) 0.93
Importance of the renin system for determining blood pressure fall with acute salt restriction in hypertensive and normotensive whites. Hypertension (2001) 0.92
Evidence for a raised concentration of a circulating sodium transport inhibitor in essential hypertension. Br Med J (Clin Res Ed) (1981) 0.92
Phenformin and metabolic acidosis. Lancet (1972) 0.92
Cognitive impairment and white matter damage in hypertension: a pilot study. Acta Neurol Scand (2008) 0.91
Harmful effects of dietary salt in addition to hypertension. J Hum Hypertens (2002) 0.91
Azathioprine for myasthenia gravis. Lancet (1972) 0.91
Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin Sci (Lond) (1992) 0.91
Letter: Hypotension during angiotensin blockade with saralasin. Lancet (1975) 0.90
Regression of atherosclerotic renal artery stenosis with aggressive lipid lowering therapy. J Hum Hypertens (2001) 0.90
Plasma atrial natriuretic peptide: its relationship to changes in sodium intake, plasma renin activity and aldosterone in man. Clin Sci (Lond) (1987) 0.90
Dietary sodium and blood pressure. JAMA (1996) 0.89
"Apparent" heart failure: a syndrome caused by renal artery stenoses. Heart (2000) 0.89
Does nifedipine reveal a functional abnormality of arteriolar smooth muscle cell in essential hypertension--the effect of altering sodium balance. J Cardiovasc Pharmacol (1985) 0.88
Relation between arterial pressure, dietary sodium intake, and renin system in essential hypertension. Br Med J (Clin Res Ed) (1981) 0.88
Optimal dose of captopril in hypertension. Lancet (1982) 0.88
Increased platelet volume and platelet mass in patients with atherosclerotic renal artery stenosis. Clin Sci (Lond) (1994) 0.88
Interference by polar metabolites in a direct radioimmunoassay for plasma aldosterone. Ann Clin Biochem (1981) 0.87
Reversal by verapamil of defect in sodium transport in leucocytes in essential hypertension. Br Med J (Clin Res Ed) (1984) 0.87
Is the renin-angiotensin-aldosterone system involved in the sodium retention in the nephrotic syndrome? Nephron (1982) 0.87
High prevalence of carotid artery disease in patients with atheromatous renal artery stenosis. Nephrol Dial Transplant (1998) 0.87
Capillary hypertension and abnormal pressure dynamics in patients with essential hypertension. Clin Sci (Lond) (1990) 0.87
Deterioration in renal function with enalapril but not losartan in a patient with renal artery stenosis in a solitary kidney. Heart (1997) 0.87
Potassium: more beneficial effects. Climacteric (2003) 0.87
Candida peritonitis treated with 5-fluorocytosine in a patient receiving hemodialysis. Clin Nephrol (1974) 0.86
The renin--angiotensin--aldosterone system in the maintenance of blood pressure, aldosterone secretion and sodium balance in normotensive subjects. Clin Sci (Lond) (1980) 0.86
Leucocyte cation transport in essential hypertension: its relation to the renin-angiotensin system. Br Med J (Clin Res Ed) (1981) 0.85
Sodium restriction in hypertensive patients treated with a converting enzyme inhibitor and a thiazide. Hypertension (1991) 0.85
Sodium intake and mortality. Lancet (1998) 0.85
Evidence that some mechanism other than the renin system causes sodium retention in nephrotic syndrome. Lancet (1982) 0.85
Angiotensin converting enzyme inhibitors in hypertension: potential problems. J Hypertens Suppl (1995) 0.85